Connect Biopharma Holdings Limited
NASDAQ:CNTB · NASDAQ Global Market
+$0.02 today
Vol 0.26M · Avg 0.28M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+84.26%
Period High
$3.69
Period Low
$0.95
Latest
$1.99
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Ovid Therapeutics Inc.
NASDAQ:OVID
$303.33M
Sutro Biopharma, Inc.
NASDAQ:STRO
$278.70M
Shattuck Labs, Inc.
NASDAQ:STTK
$236.64M
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
$211.08M
Context Therapeutics Inc.
NASDAQ:CNTX
$127.71M
InflaRx N.V.
NASDAQ:IFRX
$115.57M
Kalaris Therapeutics Inc
NASDAQ:KLRS
$80.98M
ImageneBio Inc
NASDAQ:IMA
$63.39M
Metagenomi, Inc. Common Stock
MGX
$45.18M
Quince Therapeutics, Inc.
QNCX
$5.20M
What is the latest CNTB filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does CNTB have?
Intrinsic Alpha currently shows 20 recent filings for CNTB.
Explore More
Continue the stock analysis
Jump to another research area for this company.